Table 3.
No. | Pathway Name | Total | Hits (all) | Hits (sig.) | p-value | Gamma P |
---|---|---|---|---|---|---|
1 | Selenoamino acid metabolism | 35 | 6 | 3 | 0.067 | 0.0,489 |
2 | Tyrosine metabolism | 160 | 28 | 6 | 0.350 | 0.068 |
3 | Fatty acid metabolism | 63 | 19 | 4 | 0.421 | 0.081 |
4 | Drug metabolism - other enzymes | 31 | 6 | 2 | 0.277 | 0.084 |
5 | Vitamin E metabolism | 54 | 21 | 4 | 0.504 | 0.091 |
6 | Fatty acid activation | 74 | 35 | 6 | 0.580 | 0.094 |
7 | Porphyrin metabolism | 43 | 15 | 3 | 0.494 | 0.097 |
8 | Methionine and cysteine metabolism | 94 | 9 | 2 | 0.478 | 0.110 |
9 | Purine metabolism | 80 | 17 | 3 | 0.584 | 0.110 |
10 | Squalene and cholesterol biosynthesis | 55 | 27 | 4 | 0.714 | 0.125 |
11 | Pyrimidine metabolism | 70 | 11 | 2 | 0.592 | 0.128 |
12 | Urea cycle/amino group metabolism | 85 | 12 | 2 | 0.641 | 0.136 |
13 | Aspartate and asparagine metabolism | 114 | 12 | 2 | 0.641 | 0.136 |
14 | Vitamin A (retinol) metabolism | 67 | 29 | 4 | 0.767 | 0.138 |
15 | Linoleate metabolism | 46 | 23 | 3 | 0.789 | 0.152 |
16 | Drug metabolism - cytochrome P450 | 53 | 15 | 2 | 0.762 | 0.163 |
17 | Xenobiotics metabolism | 110 | 15 | 2 | 0.762 | 0.163 |
18 | De novo fatty acid biosynthesis | 106 | 34 | 4 | 0.867 | 0.170 |
19 | Glycosphingolipid metabolism | 67 | 17 | 2 | 0.822 | 0.181 |
20 | Carnitine shuttle | 72 | 21 | 2 | 0.902 | 0.215 |
21 | Bile acid biosynthesis | 82 | 23 | 2 | 0.929 | 0.232 |
22 | Androgen and estrogen biosynthesis and metabolism | 95 | 45 | 4 | 0.968 | 0.243 |
23 | Glycerophospholipid metabolism | 156 | 29 | 2 | 0.973 | 0.281 |
24 | D4 & E4-neuroprostane formation | 37 | 32 | 2 | 0.984 | 0.305 |
25 | Leukotriene metabolism | 92 | 44 | 3 | 0.989 | 0.305 |
26 | C21-steroid hormone biosynthesis and metabolism | 112 | 60 | 4 | 0.996 | 0.347 |
27 | Prostaglandin formation from arachidonate | 78 | 50 | 3 | 0.996 | 0.347 |